Growth Metrics

Pacific Biosciences Of California (PACB) Change in Inventory (2016 - 2026)

Pacific Biosciences Of California has reported Change in Inventory over the past 15 years, most recently at -$3.5 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 50.42% year-over-year to -$3.5 million; the TTM value through Dec 2025 reached $1.4 million, down 82.94%, while the annual FY2025 figure was $1.4 million, 82.94% down from the prior year.
  • Change in Inventory for Q4 2025 was -$3.5 million at Pacific Biosciences Of California, down from $1.1 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $13.3 million in Q1 2023 and troughed at -$9.0 million in Q4 2023.
  • A 5-year average of $3.7 million and a median of $3.1 million in 2023 define the central range for Change in Inventory.
  • Biggest five-year swings in Change in Inventory: surged 660.88% in 2021 and later tumbled 185.47% in 2023.
  • Year by year, Change in Inventory stood at $7.7 million in 2021, then soared by 37.66% to $10.5 million in 2022, then tumbled by 185.47% to -$9.0 million in 2023, then grew by 21.47% to -$7.1 million in 2024, then skyrocketed by 50.42% to -$3.5 million in 2025.
  • Business Quant data shows Change in Inventory for PACB at -$3.5 million in Q4 2025, $1.1 million in Q3 2025, and $1.3 million in Q2 2025.